First National Bank of Omaha’s Bristol-Myers Squibb BMY Stock Holding History

First National Bank of Omaha’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Hold	4,165	–	–	0.01%	484
2026 Q1	$249K	Sell	4,165 -131	-3%	-$7.64K	0.01%	474
2025 Q4	$233K	Buy	+4,296	New	+$207K	0.01%	481
2024 Q3	–	Sell	-16,021	Closed	-$665K	–	304
2024 Q2	$665K	Buy	+16,021	New	+$717K	0.04%	235
2024 Q1	–	Sell	-63,474	Closed	-$3.26M	–	312
2023 Q4	$3.26M	Sell	63,474 -83,108	-57%	-$4.36M	0.21%	136
2023 Q3	$8.51M	Sell	146,582 -9,210	-6%	-$564K	0.55%	52
2023 Q2	$9.96M	Buy	155,792 +3,482	+2%	+$233K	0.57%	51
2023 Q1	$10.6M	Buy	152,310 +15,594	+11%	+$1.1M	0.64%	46
2022 Q4	$9.84M	Buy	136,716 +63,597	+87%	+$4.8M	0.61%	52
2022 Q3	$5.2M	Sell	73,119 -2,597	-3%	-$188K	0.34%	97
2022 Q2	$5.83M	Buy	75,716 +203	+0.3%	+$15.5K	0.35%	93
2022 Q1	$5.51M	Buy	75,513 +11,863	+19%	+$797K	0.28%	111
2021 Q4	$3.97M	Buy	63,650 +10,438	+20%	+$612K	0.19%	144
2021 Q3	$3.15M	Buy	53,212 +43,589	+453%	+$2.87M	0.16%	152
2021 Q2	$607K	Hold	9,623	–	–	0.03%	268
2021 Q1	$607K	Buy	9,623 +32	+0.3%	+$1.99K	0.03%	268
2020 Q4	$595K	Sell	9,591 -742	-7%	-$45.6K	0.03%	267
2020 Q3	$623K	Buy	10,333 +1,370	+15%	+$82.5K	0.04%	244
2020 Q2	$527K	Sell	8,963 -5,481	-38%	-$328K	0.04%	256
2020 Q1	$805K	Sell	14,444 -1,955	-12%	-$119K	0.06%	209
2019 Q4	$1.05M	Buy	16,399 +185	+1%	+$10.6K	0.06%	215
2019 Q3	$822K	Buy	16,214 +1,565	+11%	+$73.6K	0.05%	229
2019 Q2	$664K	Buy	14,649 +570	+4%	+$26.6K	0.04%	253
2019 Q1	$672K	Buy	14,079 +20	+0.1%	+$996	0.05%	242
2018 Q4	$731K	Buy	14,059 +500	+4%	+$26.9K	0.06%	230
2018 Q3	$842K	Sell	13,559 -599	-4%	-$35.5K	0.05%	299
2018 Q2	$783K	Sell	14,158 -591	-4%	-$31.9K	0.05%	301
2018 Q1	$933K	Sell	14,749 -1,600	-10%	-$103K	0.06%	289
2017 Q4	$1M	Sell	16,349 -15	-0.1%	-$938	0.06%	288
2017 Q3	$1.04M	Buy	16,364 +3,208	+24%	+$187K	0.06%	271
2017 Q2	$733K	Sell	13,156 -2,163	-14%	-$118K	0.05%	304
2017 Q1	$833K	Sell	15,319 -605	-4%	-$33.2K	0.05%	294
2016 Q4	$931K	Buy	15,924 +70	+0.4%	+$3.83K	0.06%	275
2016 Q3	$855K	Buy	15,854 +905	+6%	+$58.1K	0.06%	211
2016 Q2	$1.1M	Hold	14,949	–	–	0.08%	174
2016 Q1	$955K	Sell	14,949 -799	-5%	-$50.4K	0.07%	188
2015 Q4	$1.08K	Sell	15,748 -950	-6%	-$62.8K	0.08%	184
2015 Q3	$989	Sell	16,698 -647	-4%	-$41K	0.07%	197
2015 Q2	$1.1K	Hold	17,345	–	–	0.08%	200
2015 Q1	$1.1K	Sell	17,345 -56	-0.3%	-$3.51K	0.08%	200
2014 Q4	$1.03M	Buy	17,401 +1	+0%	+$56	0.07%	208
2014 Q3	$891K	Sell	17,400 -2,152	-11%	-$107K	0.06%	218
2014 Q2	$949K	Buy	19,552 +252	+1%	+$12.4K	0.07%	220
2014 Q1	$1M	Buy	19,300 +1,650	+9%	+$87.8K	0.07%	214
2013 Q4	$938K	Sell	17,650 -5,540	-24%	-$282K	0.07%	210
2013 Q3	$1.07M	Sell	23,190 -225	-1%	-$9.88K	0.09%	181
2013 Q2	$1.05K	Buy	+23,415	New	+$1.02M	0.09%	179

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

First National Bank of Omaha's BMY Position: Q2 2026 in Review

First National Bank of Omaha held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,165 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #484.

First National Bank of Omaha first reported a position in BMY in Q2 2013 and has held it in 47 quarters since. The position peaked at $10.6M in Q1 2023. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

First National Bank of Omaha held 4,165 shares of Bristol-Myers Squibb worth $244K as of Q2 2026.
First National Bank of Omaha left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of First National Bank of Omaha's portfolio in Q2 2026, its #484 holding.
First National Bank of Omaha first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 47 quarters since.
First National Bank of Omaha's Bristol-Myers Squibb position peaked at $10.6M in Q1 2023.
1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First National Bank of Omaha's 13F filing for Q2 2026, filed 7 Aug 2026.